Using genetic research to treat inflammatory diseases Vienna centre of excellence in biomedicine harnesses basic research

Vienna centre of excellence in biomedicine harnesses basic research to quest for new therapies

Austrias first centre of excellence in biomedicine, Vienna based Bio Molecular Therapeutics (BMT), is going from strength to strength. With a workforce of over 60 and an annual budget of more than EUR 3.63 million, BMT is currently working on four major projects. The centre is researching into the genetic causes of chronic inflammatory diseases such as rheumatism and arteriosclerosis, inflammation of the gastro-intestinal tract, and disorders of the immune system.

BMT is a research association the only one of its kind in Austria that brings together leading university institutes, pharmaceutical companies, and domestic and foreign start-ups in order to achieve rapid transfers of research results from the laboratory to the patient. There is much to be gained, as the present lack of effective treatments for these widespread diseases is to blame for severe disabilities and about half of all fatalities. Although it was founded only two years ago, BMT can already point to palpable success in the form of international publications, patent registrations and promising new therapeutic approaches.

The decoding of the human genome is widely regarded as a milestone in the history of the biosciences. Less well known is the fact that the real purpose of these endeavours is to identify the genetic origins of diseases. BMT a line-up of ten commercial and scientific partners with complementary areas of expertise is in the forefront of these efforts. The chosen organisational and managerial set-up of the centre is aimed at ensuring that relevant research results are applied, in the interests of patients.

BMTs operational partners are the Medical Faculty of the University of Vienna (the Institute of Vascular Biology and Thrombosis Research, the Institute of Immunology, and the Department of Immunodermatology and Infectious Skin Diseases, University Clinic

Contact: Gudrun Baumann
PR&D Public Relations for Research & Development

Page: 1 2 3

Related biology news :

1. Using statistics to decipher secrets of natural mutation
2. Using science to restore habitat for declining species
3. Using soils as filters to prevent crypto from moving to the groundwater
4. Using a companion crop to control weeds organically
5. Using plants and microbes to purify polluted industrial wastewater
6. Using GPR to estimate tree root biomass
7. Using computational power tools to bolster systems biology
8. Using RNA interference to tune gene activity in stem cells
9. Using sewage sludge as fertilizer
10. Using the oceans living light shows to fight terrorism or track the planets most massive migration
11. Using brain activity to identify risk for disorders

Post Your Comments:

(Date:6/6/2019)... ... June 05, 2019 , ... MedTech Breakthrough , an ... and medical technology market, announced that it has selected Medacta International’s MySpine® MC ... in the 2019 MedTech Breakthrough Awards program. , Medacta® is ...
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, up 12% ... combined with successful roll-out of strategic investments & operational excellence initiatives worldwide. , ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG ... seizure risk signals, usually based on variations of amplitude, frequency or spike train ... diagnostic methodology due to the complexity and variability of the signal, and automation ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... BETHESDA, Md. and ROANOKE, Va. (PRWEB) , ... ... ... virtual care optimized for microlearning engagement, and Carilion Clinic, a national leader in ... leveraging the latest in virtual care. , Mytonomy recently deployed its ...
(Date:6/11/2019)... ... June 11, 2019 , ... A ... mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying ... on mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
Breaking Biology Technology:
Cached News: